Cite
HARVARD Citation
Mosińska, P. et al. (2018). FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS. Neurogastroenterology & motility. 30 (5), p. n/a. [Online].